Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Fake malaria drug implicated in Burmese man’s death

13.06.2006
A 23-year old man in Burma with malaria died because the medicine he received was fake, according to an investigative report by an international team of researchers published in PLoS Medicine.

The patient went to a rural hospital in East Burma with a fever and was diagnosed as having a straightforward case of falciparum malaria. He was treated with the vital antimalarial drug artesunate, labeled as made by the company Guilin Pharmaceutical in China. This drug is usually extremely effective, yet the patient went into a coma and died.

The researchers, led by Paul Newton (University of Oxford), analyzed the artesunate tablets that had been used to treat the patient and found that they were fake, containing just 20% of the amount of active drug present in a genuine artesunate tablet.

When genuine artesunate was given to 600 patients with straightforward falciparum malaria in a study in East Burma, every single patient survived. Newton and colleagues conclude that the 23-year old man died from being given fake artesunate.

“Counterfeit artesunate continues to circulate on a vast scale in mainland Southeast Asia,” say the authors. So far, only the Guilin Pharmaceutical brand of artesunate has been counterfeited.

Genuine artesunate is relatively expensive, creating a demand among poor, vulnerable people for cheaper alternatives—the counterfeiters, say the authors, are thus preying upon the poor.

Newton and colleagues fear that an epidemic of fake artesunate may also follow in the wake of the genuine artesunate that is being imported for use in sub-Saharan Africa, where the burden of malaria is greatest. The high cost and the shortage of genuine artesunate in Africa provide a favorable situation for the spread of fakes, which could put the lives of thousands of children at risk.

Fake artesunate was found in Cameroon in 2005, and fake dihydroartemisinin (a related antimalarial drug) was reported in Tanzania in 2001.

“Because of inadequate systems for the monitoring of the quality of antimalarial medicines in Africa,” say the authors, “and because few have looked for it, counterfeit artesunate may already be widespread.”

“We make no apology for the use of the term manslaughter to describe this criminal lethal trade,” they say. “Indeed, some might call it murder. Somewhere, people are directing a highly technical and sophisticated criminal trade.”

Preventing an epidemic of fake artesunate in Africa, they say, will require concerted global action, including ensuring that genuine artesunate is made affordable to the poorest.

Andrew Hyde | alfa
Further information:
http://www.plosmedicine.org

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>